TissueGene

TissueGene -ECA Direct Loan

Borrower(s)
TissueGene
Industry
Manufacturing & equipment/Pharmaceuticals
Area of finance
Export & Agency Finance
Region
North America
North America
Countries
United States

Deal Overview

The bank will invest in TissueGene, which is developing Invossa, the world's first gene therapy for degenerative arthritis. Unlike existing treatments for degenerative arthritis, the new drug will alleviate pain and treat symptoms at the same time.   Invossa obtained approval for...

show more
Deal Volume
$10m
Financial Close
15/05/2016
Dealmakers
Sources

Did you work on this deal ?

This deal page needs more information from those involved.

Tag yourself TAG A COLLEAGUE SUGGEST AN EDIT

Tranches

To view all tranche and pricing information, login or upgrade to a subscription here